ResMed posts 'strong' double-digit growth
By HME News Staff
Updated Fri October 27, 2017
SAN DIEGO - ResMed reported revenues of $523.7 million for the first quarter ended Sept. 30, 2017, a 13% increase compared to the same period of the prior year. It reported a net income of $86.1 million, a 13% increase. For the Americas specifically, ResMed reported revenues of $296.6 million for the first quarter of fiscal year 2018, an 11% increase compared to the same period of the prior year. “We started the fiscal year with strong 11% constant currency revenue growth led by our masks, software-as-a-service solutions and devices,” said Mick Farrell, CEO. “Our new masks have performed well around the world, device sales are solid, and operating profit returned to double-digit growth in the quarter.” On the same day it announced financial results, ResMed's board of directors also declared a quarterly cash dividend of $0.35 per share. The dividend will have a record date of Nov. 9, 2017, payable on Dec. 14, 2017.
Comments